1 option
Clinical immunology / Reginald Gorczynski, Jacqueline Stanley.
Levy Dental Medicine Library - Stacks RC582 .G67 1999
Available
- Format:
- Book
- Author/Creator:
- Gorczynski, Reginald M.
- Language:
- English
- Subjects (All):
- Clinical immunology.
- Immunity.
- Immune System.
- Medical Subjects:
- Immunity.
- Immune System.
- Physical Description:
- 403 pages : illustrations ; 21 cm
- Place of Publication:
- Austin, TX : Landes Bioscience, 1999.
- Contents:
- Section I Essential Immunobiological Concepts in Clinical Immunology 1
- 1. An Introduction: The Immune System 2
- The Immune System 3
- Innate Immune Responses 4
- Adaptive Immune Responses 6
- Cells That Function in Innate Immune Responses 8
- Cells That Function in Adaptive Immune Responses 11
- Tissues of the Immune System: General Features 12
- Tissues of the Immune System: Primary Lymphoid Organs 12
- Tissues of the Immune System: Secondary Lymphoid Tissues 14
- Soluble Mediators of the Immune System 20
- Molecules That Activate Lymphocytes 22
- Molecules That Activate Lymphocytes: Monoclonal Activators 22
- Molecules That Activate Lymphocytes: Oligoclonal Activators 24
- Molecules That Activate Lymphocytes: Polyclonal Activators 24
- 2. Innate Immune Responses to Pathogens 31
- Innate Immune Responses to Pathogens 32
- Role of Complement 32
- Phagocytosis 32
- Genetic Defects in NADPH Oxidase: Chronic Granulomatous Disease 42
- Natural Killer Cells 42
- Eosinophils 45
- 3. Antigen Presenting Cells 51
- Antigen Presenting Cells 51
- Antigen Presenting Molecule: General Features 55
- Antigen Presenting Molecule: Class I MHC Molecules 56
- Antigen Presenting Molecules: Class II MHC Molecules 61
- Antigen Presenting Molecules: CD1 Molecules 64
- 4. Soluble Mediators of Immunity I: Antibodies 69
- Antibodies 69
- Structure Function Relationship of Antibodies 71
- Properties of Immunoglobulin Isotypes 72
- Monoclonal Antibodies 77
- Monoclonal Antibodies as Therapeutic Agents 78
- Clinical Trials 79
- 5. Soluble Mediators of Immunity II: Complement 85
- Complement 86
- Complement Pathways: General Features 86
- Complement Biological Activities 93
- Complement Regulation 95
- Complement and Coagulation Pathways Are Linked via Kallikrein 99
- Complement Genetic Deficiencies 99
- Role of Complement in Medicine 103
- Xenotransplantation: Complement Is Deleterious 103
- 6. Soluble Mediators of Immunity III: Cytokines 110
- Cytokines 111
- Cytokine Receptors That Engage the JAK/STAT Pathway 111
- Cytokine Receptors That Engage SMADs 117
- Biological Activities of Cytokines That Signal via the JAK/STAT Pathway 117
- Clinical Relevance of Cytokines 120
- Chemokines 124
- 7. Cells of Adaptive Immunity 130
- B-lymphocyte Antigen-specific Receptor 130
- Constructing an Immunoglobulin 131
- B-cell Differentiation: Bone Marrow 134
- Clinical Significance: B-cell Neoplasms 137
- T-lymphocyte Antigen-specific Receptor 137
- Differentiation of Lymphoid Progenitor Cells in the Thymus 140
- Transport of Lymphocytes from Primary to Secondary Lymphoid Tissues 146
- 8. Antigen Dependent B-cell Differentiation 153
- Antigen Dependent B-cell Differentiation 153
- Fate of Activated B Cells in Germinal Centers 155
- Primary versus Secondary Immune Responses 159
- Clinical Significance 159
- Models of Signal Transduction in B-cell Activation 160
- Negative Signaling in B Cells 161
- B-cell Responses to T-independent Antigens 163
- 9. T Lymphocytes 168
- CD4[superscript +] T cells: Antigen Induced Differentiation 168
- Memory CD4[superscript +] T Cells 174
- Clinical Relevance of Type 1 versus Type 2 Cytokines 175
- CD8[superscript +] T Cells: Antigen Induced Differentiation 177
- Memory CD8[superscript +] T Cells 179
- Clinical Relevance CD8[superscript +] T Cells 179
- Model of Signal Transduction in T-cell Activation 180
- Negative Regulation of T-cell Signaling 182
- Memory Lymphocytes in Immunosurveillance 182
- Gamma/Delta T Cells 184
- 10. Inflammation 190
- Inflammation 191
- Vasodilatation, Increased Vascular Permeability and Edema 191
- Recruitment of Neutrophils and Monocytes to the Site of Inflammation 195
- Adaptive Immune Responses in Inflammation 202
- Role of Innate and Adaptive Immunity in Inflammation 203
- Clinical Relevance 204
- 11. Immunological Responses to Microbes 211
- Immunity to Microbes 212
- Host Defenses to Extracellular Bacteria 212
- Resistance to Immunity: Extracellular Bacteria 217
- Host Defenses to Viruses 217
- Resistance to Immunity: HIV 222
- Host Defenses to Intracellular Bacteria 224
- Resistance to Immunity: Intracellular Bacteria 226
- Host Defenses to Fungi 227
- Resistance to Immunity: Fungi 229
- Section II Clinical Immunology in Practice 239
- 12. Immunization 240
- Immunization 241
- Passive Immunization 242
- Active Immunization or "Vaccination" 244
- Forms of Vaccines 247
- Vaccine Efficacy and Safety 254
- Successful Application of Vaccine Technology 255
- Limited Use Vaccines and Experimental Vaccines 256
- Uses of Vaccines (for Other than Control of Infection) 258
- 13. Hypersensitivity Reactions 266
- Hypersensitivity Reactions 267
- Type I Immediate Hypersensitivity Reactions 267
- Type II Antibody-mediated Hypersensitivity Reactions 272
- Type III Immune-complex Mediated Hypersensitivity 276
- Type IV Cell-mediated Hypersensitivity 278
- 14. Autoimmunity 289
- Autoimmunity 290
- Tolerance Induction 290
- Loss of Self Tolerance 293
- Immunopathology of Autoimmune Disorders: Autoreactive Antibodies 296
- Immunopathology of Autoimmune Disorders: Cell Mediated Immunity 299
- Immunotherapy of Autoimmune Disease: Suppression 301
- Immunotherapy of Autoimmune Disorders: Cytokine Modulation 306
- 15. Immunodeficiency Disorders 314
- Immunodeficiency Disorders 315
- General Features 315
- Primary Immunodeficiency Disorders 315
- Primary Immunodeficiency Disorders: Progenitor Cells 315
- Primary Immunodeficiency Disorders: T Cells 319
- Primary Immunodeficiency Disorders: B Cells 320
- Primary Immunodefieciency Disorders: Phagocytic 323
- Primary Immunodeficiency Disorders: Other Leukocytes 323
- Primary Immunodeficiency Disorders: Complement System 323
- Secondary Immunodeficiency Disorders 327
- Secondary Immunodeficiency Disorders: Acquired 329
- Secondary Immunodeficiency Disorders: Abnormal Production of Immune Components 330
- 16. Tumor Immunology 337
- Tumor Immunology 338
- The Concept of Immunosurveillance 338
- Tumor Antigens 340
- Tumor Immunosurveillance 344
- Effector Mechanisms for Elimination of Tumors 345
- Evasion of Immune Surveillance 349
- Immunology in Diagnosis or in Monitoring Prognosis 354
- Novel Therapies: Enhancing Antigen Presentation by Dendritic Cells 355
- Novel Therapies: Cytokines and other Molecules Transfected into Tumor Cells Themselves 357
- Novel Therapies: Modification of CTL as a Strategy for Enhancing Tumor Immunity 359
- Novel Therapies: Monoclonal Antibodies and Immunotherapy 359
- 17. Transplanation 367
- Transplantation 368
- Classification of Grafts According to Their Source 368
- Classification of Graft Rejection 371
- Genetics of Transplantation 373
- Immunology of Graft Rejection 379
- Tissue Differences in Clinical Transplantation 387
- Graft Versus Host Disease 389
- Immunosuppression in Transplantation 389.
- Notes:
- "Vademecum."
- Includes index.
- ISBN:
- 1570596255
- OCLC:
- 41453018
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.